End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
114,200 KRW | +2.79% | +6.83% | -25.46% |
May. 22 | Nomura Upgrades Lotte Chemical to Buy From Neutral; Price Target is KRW160,000 | MT |
May. 16 | Lotte Chemical Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
- The company has a good ESG score relative to its sector, according to Refinitiv.
Strengths
- The company is one of the most undervalued, with an "enterprise value to sales" ratio at 230.58 for the 2024 fiscal year.
- The company's share price in relation to its net book value makes it look relatively cheap.
- Analysts have consistently raised their revenue expectations for the company, which provides good prospects for the current and next years in terms of revenue growth.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- The opinion of analysts covering the stock has improved over the past four months.
Weaknesses
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- The company has insufficient levels of profitability.
- The group shows a rather high level of debt in proportion to its EBITDA.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
- Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Commodity Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-25.46% | 3.54B | B+ | ||
+1.55% | 39.16B | B- | ||
-24.95% | 20.7B | B- | ||
-20.96% | 12.32B | B- | ||
-9.19% | 9.86B | A- | ||
-17.82% | 9.26B | B+ | ||
+27.16% | 8.42B | C+ | ||
+5.27% | 6.56B | C+ | ||
-30.92% | 5.24B | C | ||
+13.98% | 2.73B | B+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- A011170 Stock
- Ratings Lotte Chemical Corporation